Comparative asessment of bacterial excrection degree depending from sensivity profile of Mycobacterium tuberculosis to antituberculosis drugs
Ключові слова:
Mycobacterium tuberculosis, tuberculosis, MDR tuberculosis, Xpert MTB/RIF, bacterial excrection, infection control.Анотація
One of the important part of the epidemiological component of tuberculosis pathomorphosis in modern conditions is the change in important biological properties of the pathogen, not only in the form of increased frequency and extension of Mycobacterium tuberculosis resistance to anti-tuberculosis drugs, but also changes in manifestations of vital activity - virulence, massivity and growth rate of culture, etc. The study purpose was to determine the growth intensity of Mycobacterium tuberculosis depending on resistance to anti-tubercuosis drugs, to assess the bacterial excretions, to compare the data of the phenotypic (Löwenstein-Jensen media) and genotypic method (Xpert MTB/RIF), to carry out the correlation analysis of the results. Materials and methods: The results of the phenotypic and genotypic tests of 148 samples have been analyzed. Group 1 included 52 samples with susceptibility of Mycobacterium tuberculosis to anti-tuberculosis drugs, group 2 - 38 samples with monoresistance to isoniazid, group 3 - 58 samples with multi-drug resistance. The bacterial excretion was assessed as: scanty - for single colonies, moderate - for 20 to 100 colonies, massive - for 100 and over. The standard assessment of positive genotypic testing by quantities of DNA copies: very small, small, moderate, great quantity. Correlation analysis has been made in SPPS static program. Results: In the 1 group results the following bacterial excretions have been noted: 30,7%- scanty, 28,8%-moderate, 40,3% massive. In the 2 group scanty bacterial excretion was identified in 36,8%, moderate in 39,1%, massive in 23,6%. In the 3 group scanty in 37,9%, moderate in 22,4% and massive bacterial excretion in 39,6%. In the genotypic testing 15 negative results have been noted, which comprised 7,7% in 1 group, 15,8%, in 2 group, 8,6% in 3 group.Very small quantity in 6,2%, 15,6%, 11,3%, Small in 27,1%, 28,1%, 28,3%, Medium quantity in 42,1%, 34,4%, 26,4%, Great quantity in 31,2%, 21,5%, 32,1% - in 1, 2, 3 group, respectively. Conclusions: Samples with different resistant strains demonstrated differs in phenotypic and genotypic features. Phenotypic method gave the possibility to detect more than 10% cases with bacterial excretion, that had negative genotypic test. Correlation analysis showed a strong and significant correlation between the indicated results, the Spirmen correlation is 0.75, Kendall - 0.66, with the reliability level p˂0.01. Inclusion of the results of genotypic test with information on the quantity of Mycobacterium tuberculosis genetic material in a patient's sputum sample, and also on Mycobacteria tuberculosis resistance, into the assessment of the tuberculosis infection hotbed will enable improvement of epidemiological control.
Посилання
Garib FYu, Rizopulu AP Interactions of pathogenic bacteria with innate immune reactions of host. Infekc. immun.2012.V. 2 N 3, p. 581–96
Zabolotko VM Indicators of tuberculosis morbidity and activity of antituberculosis institutions in 2016. Ukrainian Ministry of Health, State Institution “ Center of medical statistic” Kiev – 2017
Nizova NM, Holubchikov V Analitical and statistical guide “Tuberculosis in Ukraine”. Ukrainian Ministry of Health, State Institution “Ukrainian center of control for socialy dangerous disiases of Ukrainian Ministry of Health”, State Institution “ Center of medical statistic”, Kiyv.Blank-Press.2015 130 P.
Vishnevskiy BI, Narvskaya OV, Vasilieva SN. Virulence of Mycobacterium tuberculosis. Problems of Tuberculosis, 2002, N. 10, p. 33–36.
Manicheva OA, Lasunskaia EB, Zhuravlev VYu, Otten TF, Mokrousov IV, Vishnevsky BI, Narvskaya OV Drug sensitivity of Mycobacterium tuberculosis in relation to their viability, cytotoxicity, genotype and current process in patients with pulmonary tuberculosis. Problems of Tuberculosis, 2008, N. 12, p. 18–22.
Koretskaya NM, Chushkina AA, Narkevich AN Epidemiological aspects of the tuberculosis pathomorphism in modern conditions. «Acta Biomedica Scientifica» 2012, N 5 (87) V 1 p. 92-94
Vishnevskiy BI, Manicheva OA, Yablonskiy PK Mycobacterium tuberculosis virulence. Infekc. Immun.2014,V.4,N4,p.319–30. doi: 10.15789/2220- 7619-2014-4-319-330
Manicheva OA, Narvskaya OV, Mokrousov IV, Vyazovaya AA, Zhuravlev VU, Barnaulov AO et al. Drug resistance, viability and virulance in vitro of Mycobacterium tuberculosis strains of different genotypes. Infekc. Immun.2011;1(4):341-348. doi:10.15789/2220-7619-2011-4-341-348
Aguilar D, Hanekom M, Mata D, Gey van Pittius N, Helden P van, Warren R, Hernandez Pando R. Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission // Tuberculosis. 2010. V. 90. p. 319–32
Epidemiologic Basis of Tuberculosis Control First edition 1999 Hans L. Rieder International Union Against Tuberculosis and Lung Disease, Paris 192 p.
Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJM. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006; 312:1944–6.
Bergval IL, Schuitema ARJ, Klatser PR, Anthony RM. Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance. J Antimicrob Chemother 2009; 64:515–23.
Order of Ukrainian Ministry of Health №250 21.05.2007 “On approval of methodological recommendations "Organization, conducting of epidemiological supervision and disinfection measures in anti-tuberculosis facilities and foci of tuberculosis”
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2019 Annals of Mechnikov's Institute
Ця робота ліцензованаІз Зазначенням Авторства – Некомерційна – Без Похідних 3.0 Міжнародна.